In effort to help spread lessons learned from clinical research to benefit people affected by diabetes, the International Diabetes Federation (IDF) and Eli Lilly have come together for the second phase of the Bringing Research in Diabetes to Global Environments and Systems program (BRIDGES 2), reaffirming their commitment to helping people with diabetes effectively manage their condition.
BRIDGES 2 will build upon the work undertaken and the lessons learned during the initial phase of the program which operated from 2007 to 2015. The program will fund and replicate a selection of projects from the initial phase, placing an emphasis on the secondary prevention of diabetes and a strong involvement of local public health authorities.
"Our goal is to translate evidence-based approaches from the first round of BRIDGES to other contexts and countries to improve the lives of people living with diabetes," Robert A. Gabbay, Chair of the Steering Group of BRIDGES 2 said.
This will enable the implementation of established evidenced-based interventions and approaches to diabetes care. BRIDGES 2 will further build on the achievements of the initial phase that resulted in 41 diabetes prevention and treatment projects supported in 36 countries. More than 400 million people are living with diabetes.
BRIDGES 2 will issue a request for grant proposals in June 2017. All grant proposals will be peer reviewed and prioritized by a cross-disciplinary external review group under the coordination of IDF. A steering committee composed with experts appointed by IDF and Lilly will determine the selection of projects and types of grants that will be available.
For more information about BRIDGES 2, visit www.idf.org/bridges.